Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens. Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Ignoring warning calls from pharma companies and the Association of the British Pharmaceutical Industry (ABPI), the UK government announced its planning to raise the revenue clawback rate paid by pharmaceutical companies on the Statutory Scheme for Branded Medicines from 24.4% to 27.5%. S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula (Greenblatt) . Dr. Kolchinsky's firm held 7.3 million Ascendis Pharma A/S (NASDAQ:ASND) shares in Q3, which were worth $1.17 billion and made up for 16.31% of its portfolio. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss When developed in combination with a medicinal asset, digital therapeutics enable significant market differentiation and significant benefits for stakeholdersfrom optimizing patient outcomes to supporting more efficient generation of compelling real-world data In this conversation. Shes currently earning her PhD in European History at Boston. Peter Kolchinsky - Insider Trading Tracker . Peter Kolchinsky owns about 10,916,567 units of Solid. Peter's mailing address filed with the SEC is C/O RA CAPITAL MANAGEMENT, L.P., 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116. Peter Kolchinsky, PhD '01, is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life sciences. Peter Kolchinsky, RA Capital's founder and managing partner, joins to talk about why so many of the policy ideas floated around drug-pricing are wrongheaded. Dr. Kolchinsky is a founder and Managing Partner of RA Capital Management, L.P., a multi-stage investment manager which is dedicated to evidence-based investing in healthcare and life science companies that are developing drugs, medical devices, and diagnostics, where he has worked since 2001. This new fund of theirs arrives well into a go-go era of new startup financing, with a particular focus on building new biotechs. Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups John Carroll Editor & Founder Josh Resnick RA Capital Peter Kolchinsky and Raj Shah have another $300. Bens got me beat so far by three perch and a bass and Im trying to catch up, 2010. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. The largest trade he's ever made was buying 4,545,455 units of Wave Life Sciences stock on 11 December 2018 worth over $50,000,005. His wife, Nora Flor, said she and her sister made calls to at least 30 centers across the US looking for the drug. In total, Peter Kolchinsky has made about 5 transactions over a year of their time at Solid Biosciences Inc. Sometimes Anna goes by various nicknames including Anna H Kolchinsky, Anna I Haas, Anna Haas Kolchinsky and Anna Haas Kolchinsky. Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by The company hired hundreds of new employees and paid . A quarters-long flurry of layoffs has caused thousands of workers in life sciences to go hunting for their next position sooner than expected, and the latest wave could make it more difficult to get new offers in hand in short order. In the companys CLEAR study of nearly 14,000 patients, Esperions drug Nexletol cut the combined risk of heart attack, stroke, cardiovascular death or the need for coronary revascularization by 13%, compared with placebo. Peter Kolchinsky, Ph.D. Welcome to the official Blue Horse Inn blog! March 31, 2020. On average, Peter trades about 366,737 units every 19 days since 2014. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $46,860,585 and over the last 8 years he sold WVE stock worth over $58,095,632. $140.3K . There are 15 older and 2 younger executives at Wave Life Sciences. He studied philosophy at Oregon State University and then earned a law degree from the University of Oklahoma. If you are considering starting your own biotech company, you will appreciate the wealth of practical information packed into The Entrepreneur's Guide to a Biotech Startup. Want this in your inbox every Saturday morning? All Rights Reserved. Add it to the rest of the money and their private deal capacity jumps to $1 billion, with $2.5 billion under management. Carl Ashley Morris who sold, In the last 5 years, insiders at Solid Biosciences Inc have sold an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Peter Kolchinsky is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and. Change), You are commenting using your Twitter account. venue for exploring their particular passions. Before moving to Anna's current city of Boston, MA, Anna lived in Woodstock VT and Carlisle MA. Peter's reported annual income is about $100 - 149,999; with a net worth that tops $50,000 - $99,999. Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High . Peter Kolchinsky Oct 5, 2018 Direct-to-Consumer (DTC) advertising: misnamed, misunderstood, and underappreciated Maligned by doctors and often parodied, appropriately regulated. The role of insurance and the value of what should be a celebrated national resource - the growing mountain of generic drugs - are overlooked and yet form the foundation of a workable solution.The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. Peter Kolchinsky The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines Paperback - Illustrated, January 17, 2020 by Peter Kolchinsky (Author) 180 ratings See all formats and editions Kindle $9.99 Read with Our Free App Audiobook $0.00 Free with your Audible trial Paperback Here we are at the BHI after a day of ripping out tile and installing shoe molding: And heres an article about us from The Vermont Standard that we thought you might enjoy. The higher rates are proposed to kick in on April 1. Peter Kolchinsky's largest purchase order was 2,206,685 units , worth over She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. Peter Kolchinsky is a biotechnology investor and a scientist. Endpoints News connected with the new chair of the generic industrys Association for Accessible Medicines, Christine Baeder, who is also Tevas COO, via video conference on Friday. Welcome back to Endpoints Weekly, your review of the weeks top biopharma headlines. Kolchinsky who spoke to senior editor Shiv Aroor as part . He co-founded and runs the Boston-based investment firm RA Capital Management, writes and teaches about biomedical entrepreneurship and its potential to transform global health, serves on the boards of several public and private drug development companies, and has served on the Board of Global Science and Technology for the National . . $20M on February 16, 2023. It will take some time, but rest assured: a coronavirus vaccine is coming, and it will work. I don't believe that temperature plays a role in the spread of Covid-19. Prevnar, a shot that prevents pneumococcal infections, is a Pfizer blockbuster. As the Independent Director of Wave Life Sciences, the total compensation of Peter Kolchinsky at Wave Life Sciences is $151,598. All Rights Reserved. Couple Number Two: Ben Ford and Keri Cole: Ben Ford was born and raised in Ames, Iowa. Catalys Pacific Fund Lp, Words cant bring Christina Aguilera down but frown lines can. Enjoy a 7-Day Free Trial Thru Mar 12, 2023! More Bens wife, Keri, grew up on a red dirt road in small-town Georgia. $12.54M on September 23, 2020. A biotech analyst bets Novavax has the best data. Wallmine is a radically better financial terminal. In addition, they want, Coming from diverse backgrounds and interests, the foursome. The campaign launched last year, targeting people in their 20s and 30s, Merz Aesthetics North America president Patrick Urban told Endpoints News at the time. These were worth $145 million and represented 2% of its portfolio. Verified account Protected Tweets @ Protected Tweets @ Well be posting shots of the different projects around the inn in the coming weeks, but first we thought you might like to know a little bit about us. Fill in your details below or click an icon to log in: You are commenting using your WordPress.com account. Arab Health 2023? Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. Hbm Healthcare Investments Cayman Ltd who bought 3,218,106 units worth Keri is currently the Chair of the Religious Studies department at St. Pauls School for Girls in Baltimore, Maryland. In this conversation. The Blue Horse Inn (AKA) Number Three Church Street and (AKA) The Lauren has a new name and four new proprietors: Peter, Anna, Ben, and Keri. Merz has previously enlisted singer-songwriters Joe Jonas and Teyana Taylor, 33 and 31 years old respectively, who tout the anti-wrinkle injection as a solution for frown lines without any unnecessary ingredients., Bioscience & Technology Business CenterThe University of KansasLawrence, Kansas. Right now, he is the most trending person in social media. The URI to TrackBack this entry is: https://bluehorseinnvermont.wordpress.com/2010/03/14/the-blue-horse-six/trackback/. Peter Kolchinsky: It has infected people in different parts of the world. But many people worry that Covid-19 will mutate and . This is where youll find the low down on whats happening in and around the BHI. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. . and Catherine James, EVP and General Counsel In . The estimated Net Worth of Peter Kolchinsky is at least $96 million dollars as of 23 June 2020. and bought an estimated value of $190.71M worth of shares. RA Capital is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are . The fund was seeded by Vertex Pharma co-founder Rich Aldrich, who invested $4 million at . "And another thread that speaks to need for insurance reform. we figured our friends and family would try to talk us out of it, said Anna. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. In addition, they want to provide guests with ample opportunities to enjoy local arts, food, and activities and look forward to collaborating with local artists, craftsmen, and business owners to come up with interesting packages. Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Solid Biosciences Inc's most recent insider trade came on January 31, 2023 by Peter Kolchinsky, Ph.D. is a biotechnology investor and a scientist. Its a longstanding agreement between the government and industry to keep medicines affordable for the National Health Service (NHS). In total, Peter Kolchinsky has made about 1 transaction recently at Dyne Therapeutics, Inc. 2004-2023 GuruFocus.com, LLC. and Peter Kolchinsky, Director Anna is excited about introducing her dressage horse Jurist to the local network of trails. $3.3K . Carl Ashley Morris, Chief Scientific Officer, He served on the Board of Global Science and Technology for the National Academy of Sciences from 2009 to 2012, is the author of "The Great American Drug Deal" and "The Entrepreneurs Guide to a Biotech Startup", and frequently writes and speaks on the future of biotechnology innovation. Everyone has been so generous with us, sharing advice and stories. But there was a new treatment he could try: a targeted radiotherapy called Pluvicto if he could get it in time. Kolchinsky Peter Net Worth 2022 and insider trades. Peter Kolchinsky usually trades in February, with the busiest year in 2023. Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock. By India Today Web Desk: With more than 22 lakh people infected, more than 1.5 lakh dead of the novel coronavirus, health experts all over the world are scrambling to understand just how did this one virus get so potent.. This investment adviser does not provide advice to individual investors. Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. Come and visit me at the Pacific Water Conference, booth 520! Data from the new InnoLead/KPMG US . Dr. Peter Kolchinsky Ph.D. serves as Independent Director of the Company. If you're already an Endpoints subscriber, enter your email below for a Keri is also a writer and is currently working on a Southern gothic novel. The co-heads of the venture at RA are Josh Resnick and Andrew Levin, working with 9 other professionals. Change), You are commenting using your Facebook account. RA Capital Management, L.P. is the investment manager of RA Capital Healthcare Fund, L.P. Coming from diverse backgrounds and interests, the foursome sees Woodstock as a venue for exploring their particular passions. Nexus is expected to participate in substantially all investments in private companies made by RA Capital alongside its main, longstanding fund, RA Capital Healthcare Fund L.P. In the interim, they plan to invite local folks in to see the changes, try out some wines, and make new friends. These are the three biggest challenges for innovators in large organizations and the three biggest enablers of success. Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract the implicit agreement between the biopharmaceutical industry and American society. Please note the magic link is Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. January 3, 2023 Feb 10th, Ed. No. The outspoken and occasionally caustic Kolchinsky is partnered with an urbane and widely-liked Shah. Past performance is a poor indicator of future performance. Hedge Fund Net Worth $4.93B Peter Kolchinsky manages more assets than 43% of other Hedge Fund Managers Average Return +0.32% Since Last Filing Last 12 Months 3 Years (Annualized) Portfolio Breakdown by Sector Portfolio Breakdown 97.31% Healthcare 1.12% Services 0.78% Technology 0.51% Financial RA Capital Management Portfolio Activity Company Name May 5, 2003 Like all mothers, Evelina Kolchinsky wanted her son, Peter, to adjust to school and do well. Covid-19. The most active traders at the company are worked in film production in Berlin for several years before returning to Boston, where she met Peter. Unlock this story instantly and join 161,900+ biopharma pros reading Endpoints daily and it's free. as vibrant from the outside as it is on the inside. The singer-songwriter and actress is the latest celebrity addition to Merz Aesthetics Beauty on Your Terms campaign for Botox rival Xeomin. Let us know if you like it and we may post more pieces with this option.) Kolchinsky Peter Ownership Network Ownership Network List of Kolchinsky Peter Name Position Linked company No Data Ownership Network Relation of Kolchinsky Peter Kolchinsky Peter Mailing Address Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. They fell in love with the historic character and natural beauty of the area and, as they met more of the towns residents, realized that Woodstock was a community that they would like to be part of. Everyone has been so generous with us, sharing advice and stories, and we hope that what we do with the inn will come to reflect the spirit of this wonderful community.. GuruFocus.com is not operated by a broker or a dealer. The most active traders at the company are Stock quotes provided by InterActive Data. This investment adviser does not provide advice to individual investors. The drug industry stands accused of charging too much. Most recently he bought 6,337,135 units of KALA stock worth $49,999,995 on 13 March 2020 . The largest trade he's ever made was buying 6,337,135 units of Kala Pharmaceuticals Inc stock on 13 March 2020 worth over $49,999,995. Gurus may be added or dropped from the GuruFocus site at any time. "Stay tuned for more covid and science explainers. Most recently he bought 4,000,000 units of WVE stock worth $80,000,000 on 23 June 2020. The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. Currently, Peter is married. For a patient who can't afford a $5,000 deductible, even slashing a $50,000 treatment's price by 90% would still leave that patient unable to afford his or her $5,000 out-of-pocket obligation. He currently manages a fund that invests in healthcare and biotechnology companies. hope that what we do with the inn will come to reflect the spirit of this wonderful community. You can see the complete history of Peter Kolchinsky stock trades at the bottom of the page. magic link that lets you log in quickly without using a password. As for Peter, As soon as we get the house in order, Im looking forward to some fishing. The Statutory Scheme, which is governed under UK law, is one of two that companies can use. Required fields are marked *. He currently manages a fund that invests in healthcare and biotechnology companies. Couple Number One: Peter and Anna Kolchinsky: Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. As for their long-term goals, Peter and Ben are determined to figure out how to maintain the house themselves, from the roof to the plumbing, by the time they retire. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. According to world-renowned virologist Peter Kolchinsky, the SARS-CoV-2 virus is nothing short of an "evil genius". Peters wife, Anna, grew up in Germany, Austria, and France, and came to Boston to attend Wellesley College. Dr. Kolchinsky's RA Capital held 9 million Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) shares worth $208.9 million which represented 2.89% of its portfolio during Q3. In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of $0 worth of shares. The estimated Net Worth of Peter Kolchinsky is at least $96.3 Million dollars as of 23 June 2020. Anna Kolchinsky was born on 03/30/1979 and is 43 years old. . Currently GuruFocus does not have mailing address information for Kolchinsky Peter. Most importantly, this book describes concrete, actionable reforms under which patients will be able to afford their treatments and society will continue to reap the benefits of medical innovation. Alfredo Naj Domingos prostate cancer was spreading. Listed on the paperwork are Tempus CEO Eric Lefkofsky and operating chief Ryan Fukushima, who is described as CEO of Pathos. Integrating digital therapeutics early in the asset development process will allow for gathering of clinical data to drive a clearer value proposition that maximizes the potential of both products Adam Levy, CFO, They know that 3 Church Street is part of Woodstocks history and hope to create a place where not only guests but also the community will feel welcome. They will be in plain English and use colorful analogies." Hbm Healthcare Investments Cayman Ltd who bought, In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. He studied philosophy at Oregon State University and then, a law degree from the University of Oklahoma. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. A hike is also under consideration for the voluntary scheme. Insider trading is most common in February, with the busiest year in 2023. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. 2004-2023 GuruFocus.com, LLC. UCLA CTSI | Accelerating Discoveries Toward Better Health | Main Peter has made over 5 trades of the Wave Life Sciences stock since 2018, according to the Form 4 filled with the SEC. Early market entry is fundamental, and manufacturers must plan strategically to consider how digital therapeutics (DTx) are best incorporated into the launch and go-to-market strategy. Industry is going to have to give "a pound of flesh," Kolchinsky argued, and he's explicit on the business practices biopharma must abandon to get a fair system that still rewards innovation. What an undertaking! Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Peter Kolchinsky Net Worth The estimated Net Worth of Peter Kolchinsky is at least Wave Life Sciences stock worth over $36,046,604 and over the last 8 years he sold WVE stock worth over $58,095,632. Peter Kolchinsky. Recently at Dyne Therapeutics, Inc, Peter Kolchinsky has sold an estimated value of $0 worth. In a 2018 article, Eric Bender argued that cancer drugs aren't worth the price we pay for them and recommended legislative measures be taken to align prices with the values drugs provide. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of savvy business sense. Early Life Peter Kolchinsky was born in the United States of America. The group has been building an incubator with 19 projects and two startups to their credit. Shes currently earning her PhD in European History at Boston College. We loved the idea of having a second home that was also an inn, but we figured our friends and family would try to talk us out of it, said Anna. The oldest executive at Wave Life Sciences Ltd. is KojiMiura, 71, who is the Independent Director. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of. The biopharmaceutical industry will be able to make a Covid-19 vaccineprobably a few of themusing various existing vaccine technologies. The name for the inn was Annas inspiration; The Blue Horse Inn speaks both to her German heritage and her love of art and horses. Peter Kolchinsky is Chairman/CEO at Research Alliance Corp II. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research . More than 100 drug developers thinned their organization charts last year. $12.69M on March 23, 2021. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. You are looking for the virus through an RT-PCR test. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. foundation had somehow failed patients by allowing Vertex to price its drugs so high that a 10 percent royalty could be worth so much. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. There are also venture partner and executive-in-residence programs to build up the bench. Peter served on the Board of Global Science and Technology for the National Academy of Sciences and writes about the biotech social contract. The real solution to affordability is hidden in plain sight amidst all the rhetoric about drug prices. Come and visit me at the Pacific Water Conference, booth 520! Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by Your email address will not be published. Ben, a storyteller and football aficionado, looks forward to evenings of camaraderie with locals and inn guests. The foursome plans to open for guests in the late spring of 2010. and bought an estimated value of $64.19M worth of shares. Pathos AI is currently in the works and attempting to raise about $40 million, per an SEC filing from this week. The malignant cells permeated his bones, kidney, lungs and liver, and in December, his oncologist told him there was no point in continuing chemotherapy treatment. Peter Kolchinsky usually trades in September, with the busiest year in 2020. Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. Dyne Therapeutics, Inc's most recent insider trade came on January 23, 2023 by The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. These things have helped him get to where he is now one of the richest people on Earth. Opinion. Berkshire Hathaway BRK.B +0.31% 's future leaders, including Greg Abel, will be expected to put many of their financial eggs in the conglomerate's basket. Peter's wife, Anna, grew up in Germany, Austria, and France, and came to Bost on to attend Wellesley College. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss The companies RA Capital expects to build will range from single-assets to broad platforms, spanning early discovery through late clinical stage, across all therapeutic areas, such as neurology, rare disorders, oncology, and cardiovascular disease, said Levin in a prepared statement. Novartis can't make enough of it, Q&A with Christine Baeder, new chair of the generic industrys AAM, UK government plans to hike revenue clawback rates beginning in April, Merz Aesthetics hands the mic to Christina Aguilera in Botox rival campaign. One of my favorite paintings is from the Blue Horses series by the German painter Franz Marc, Anna explained, and, of course, horses were what brought the couple to Woodstock in the first place. Health Care. Quality, Value, Ownership Undervalued - Ebit/EV + B/M Blend Quality, Value, Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High Insider Selling High Insider Buying